ClinicalTrials.gg
CompletedNCT02409836Updated Apr 7, 2015

A Study to Assess the Ingestion of Dentifrice by Children

An interventional study of Marketed Dentifrice and Marketed Flavored Dentifrice in Healthy Individuals, sponsored by Procter and Gamble. Completed at 1 site in United States. Open to participants aged 2 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-04-07.

Sponsored by Procter and Gamble · Not applicable and Interventional

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
2 Years to 12 Years
Sex
All
01

Study summary

The objective of this study was to examine the amount of dentifrice ingested and used by various age groups of children.

02

Conditions studied

  • Healthy Individuals
03

In context

Lead sponsor

Procter and Gamble is the lead sponsor of 83 studies on the registry; none are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 10 (100%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be between the ages of 2 and 12, inclusive
  • Be healthy, with no illness that, in the judgment of the investigator or examining dentist, would interfere with the conduct of the test
  • Be currently, and have been for at least three months immediately prior to the start of the study, brushing (or being brushed by care giver) their teeth on a daily basis
  • Have parent/guardian complete and return the consent form

Exclusion criteria

Exclusion Criteria:

  • Have diabetes
  • Be on dialysis
  • Have an oral health condition that, in judgment of investigator or study medical personnel, could interfere with the conduct of the study.
  • Wear metal braces
  • Have an incomplete or missing consent form
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
90 participants (actual)

Study arms

  • Active comparator
    Crest Cavity Protection

    Marketed Dentifrice

    Drug: Marketed Dentifrice

  • Active comparator
    Crest for Kids Hawaiian Punch Paste

    Marketed Dentifrice

    Drug: Marketed Flavored Dentifrice

  • Active comparator
    Crest for Kids Bubble Gum Paste

    Marketed Dentifrice

    Drug: Marketed Flavored Dentifrice

Interventions

  • DrugMarketed Dentifrice

    Marketed Dentifrice

  • DrugMarketed Flavored Dentifrice

    Hawaiian Punch Flavored

  • DrugMarketed Flavored Dentifrice

    Bubble Gum Flavored

06

What researchers measure

Primary outcomes

  1. Level of dentifrice ingested and used by various age groups of children.

    Time frame: 10 weeks

Secondary outcomes

  1. Dentifrice ingestion amount as a function of dentifrice flavor and age of participants.

    Time frame: 10 weeks

07

Study locations

1 site
  • Hill Top Research, Inc.
    Cincinnati, Ohio 45242, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 1993, a primary completion of Jul 1993 and a completion of Jul 1993. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 24, 2015
First posted
Apr 7, 2015
Start
May 1993
Primary completionActual
Jul 1993
CompletionActual
Jul 1993
Last update
Apr 7, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 7, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02409836
Lead sponsor
Procter and Gamble
Responsible party
Sponsor
First posted
Apr 7, 2015
Start date
May 1993
Primary completion
Jul 1993
Completion
Jul 1993
Last update
Apr 7, 2015

Study contacts

John E Wild
principal investigator · HIlltop Research Inc.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion